Stem cells have yet to make it into mainstream civilian medicine, but that hasn't stopped the US military betting on them to save its personnel if there's a nuclear explosion or radiological attack.
On 3 January, the Department of Defense awarded a contract to two biotech firms to develop a treatment for radiation sickness based on stem cells extracted from the bone marrow of healthy adult donors. If the treatment, known as Prochymal, wins approval from the Food and Drug Administration, the Pentagon will purchase up to 20,000 doses at a total cost - including funding for development - of $224.7 million.
High doses of radiation kill by damaging the DNA of fast-dividing cells in the gut and bone marrow. If victims survive the diarrhoea, intestinal bleeding and loss of water caused by damage to their gut linings, they may succumb to fatal infections in the following weeks as ...
continune at:http://www.newscientist.com/article/mg19726383.200-us-funds-stemcell-therapy-for-radiation-sickness.html
บทความใหม่กว่า บทความที่เก่ากว่า หน้าแรก
0 ความคิดเห็น:
แสดงความคิดเห็น